RecruitingNot ApplicableNCT07621679

People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Enrollment

28 participants

Start Date

May 7, 2026

Study Type

INTERVENTIONAL

Conditions

Osteoporosis

Summary

The aim of the Walk BEST study is to provide evidence that it is feasible to implement the technology assisted gait- focused walking program Walk-BEST™ in older adults with osteoporosis, and that this program is acceptable to this population.

Eligibility

Min Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Device: Heel2Toe[TM] sensor and a behavioral approach called Technology-assisted therapeutic walking program for people with osteoporosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 70 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDevice: Heel2Toe[TM] sensor

Heel2Toe is a new generation of wearables that provides real-time auditory feedback when the person takes a good step, one in which the step is initiated with a strong heel strike.

BEHAVIORALTechnology-assisted therapeutic walking program

Co-designed, evidence-based technology-assisted, therapeutic walking program developed by physiotherapy researchers, clinicians, and frail and non-frail seniors. It consists of training elements (derived through international consensus and endorsed by 600 older Canadians) for optimal gait pattern with the use of a biofeedback device, the Heel2Toe™ sensor, which is introduced to reinforce the gait optimizing training and encourage home practice.